世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000043046

2025〜2030年の中国の分子診断市場 - 2025年におけるサプライヤーシェア、国別の分析装置導入台数と戦略、2025〜2030年における感染症、遺伝子、がん、法医学、親子鑑定検査における数量と販売セグメント予測

VPGMarketResearch

2025-2030 China Molecular Diagnostics Market: 2025 Supplier Shares, Analyzer Installed Base and Strategies, 2025-2030 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests

発刊日 2025/11/15

言語英語

体裁PDF

ライセンス/価格

0000043046

Local PDF
Global PDF

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

LeadingMarketResearch.com のこのデータベースは、感染症、遺伝性疾患、がん診断、法医学および親子鑑定アプリケーションに関する2024年のサプライヤーシェア、2024 〜 2028年の数量と売上予測、および主要な検査用の新技術や製品を開発または販売している企業の包括的なリストを提供します。

主要企業

  • Abbott
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Cepheid/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Decode Genetics
  • Diasorin
  • 栄研化学(Eiken Chemical)
  • Elitech Group
  • Enzo Biochem
  • Exact Sciences
  • 富士レビオ(Fujirebio)
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • LabCorp/Sequenom
  • Leica Biosystems/Kreatech
  • Li-Cor Biosciences
  • Myriad Genetics
  • Proteome Sciences
  • Qiagen
  • Quest Diagnostics
  • QuidelOrtho
  • Roche
  • 島津製作所(Shimadzu)
  • Siemens Healthineers
  • タカラバイオ(Takara Bio)
  • Tecan Group
  • Thermo Fisher

レポート詳細

図表

List of Tables
Molecular Diagnostics Test Volume and Sales Forecasts by Major Application
Molecular Diagnostics Test Volume by Major Application
Major Infectious Disease Test Volume by Assay
Major Infectious Disease Test Volume by Method
Molecular Diagnostics Market by Major Application
Major Infectious Disease Diagnostics Market by Assay
Major Companies Developing or Marketing Salmonella Molecular Diagnostic Tests
Major Companies Developing or Marketing AIDS Molecular Diagnostic Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic tests
Major Companies Developing or Marketing EBV Molecular Diagnostic Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases

この商品のレポートナンバー

0000043046

最近見たレポート

急性疼痛薬の世界市場洞察(2025年)- 2030年までの分析と予測(市場参加者別、地域別、技術別、製品タイプ別)

Acute Pain Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

2025/10/04

3,500 USD

世界の近赤外線イメージングの市場規模、トレンド、機会分析レポート ― 製品別(デバイス(近赤外線蛍光イメージングシステム、近赤外線蛍光・生物発光イメージングシステム)、試薬(インドシアニングリーン(ICG)、その他の試薬))、適応症別(前臨床イメージング、がん手術、消化器手術、心血管手術、形成外科・再建手術、その他の用途)、最終用途別(病院・診療所、製薬・バイオテクノロジー企業、研究機関)、および予測(2024〜2035年)

Global Near Infrared Imaging Market Size, Trend & Opportunity Analysis Report, by Product (Devices (Near-infrared Fluorescence Imaging Systems, Near-infrared Fluorescence & Bioluminescence Imaging Systems), Reagents (Indocyanine Green (ICG), Other Reagents)), Indication (Preclinical Imaging, Cancer Surgeries, Gastrointestinal Surgeries, Cardiovascular Surgeries, Plastic/Reconstructive Surgeries, Other Applications), End Use (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Research Laboratories), and Forecast, 2024-2035

2025/10/22

2,950 USD

HPV検査およびパップテスト市場 (2025年 - 2033年)

HPV Testing And Pap Test Market (2025 - 2033)

2025/11/01

5,950 USD

フラグメント解析市場 (2025年 - 2033年)

Fragment Analysis Market (2025 - 2033)

2025/12/01

5,950 USD

世界のバイオアクティブドレッシング市場規模、トレンド、機会分析レポート ― 製品別(ハイドロコロイド、アルギン酸塩ドレッシング、皮膚代替物、抗菌性ドレッシング、その他の製品)、用途別(創傷、火傷、潰瘍、その他)、特性タイプ別(非抗菌性ドレッシング、抗菌性ドレッシング)、エンドユーザー別(病院・診療所、在宅ケア施設、長期ケア施設、その他)、および予測(2025〜2035年)

Global Bioactive Dressings Market Size, Trend & Opportunity Analysis Report, by Product (Hydrocolloids, Alginate Dressing, Skin Substitutes, Antimicrobial Dressing, and Other Products), Application (Wounds, Burns, Ulcers, and Other Applications), Property Type (Non-Antimicrobial Dressing, Antimicrobial Dressing), End User (Hospital & Clinics, Home care Settings, Long-Term care Facilities, Other), and Forecast, 2025-2035

2025/12/03

2,950 USD

カンナビジオール市場 (2026年 - 2033年)

Cannabidiol Market (2026 - 2033)

2025/12/01

5,950 USD

TOP